Commentary on “Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04–75.” Hahn NM, Stadler WM, Zon RT, Waterhouse D, Picus J, Nattam S, Johnson CS, Perkins SM, Waddell MJ, Sweeney CJ; Hoosier Oncology Group, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN

H. Barton Grossman

doi:10.1016/j.urolonc.2011.11.019

Commentary on “Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04–75.” Hahn NM, Stadler WM, Zon RT, Waterhouse D, Picus J, Nattam S, Johnson CS, Perkins SM, Waddell MJ, Sweeney CJ; Hoosier Oncology Group, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2011.11.019 ◽

2012 ◽

Vol 30 (2) ◽

pp. 228-229

Author(s):

H. Barton Grossman

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Cancer Center ◽

Oncology Group ◽

Indiana University ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Carcinoma

Download Full-text

Re: Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab as First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

The Journal of Urology ◽

10.1016/j.juro.2011.11.077 ◽

2012 ◽

Vol 187 (3) ◽

pp. 881-882

Author(s):

David P. Wood

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Oncology Group ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11351956.12361054 ◽

2011 ◽

Author(s):

Thomas Flaig

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Oncology Group ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Metastatic Urothelial Carcinoma

Download Full-text

Mature results from Hoosier Oncology Group GU04-75 phase II trial of cisplatin (C), gemcitabine (G), and bevacizumab (B) as first-line chemotherapy for metastatic urothelial carcinoma (UC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4541 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4541-4541 ◽

Cited By ~ 5

Author(s):

N. M. Hahn ◽

W. M. Stadler ◽

R. Zon ◽

D. M. Waterhouse ◽

J. Picus ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Oncology Group ◽

First Line ◽

Metastatic Urothelial Carcinoma ◽

Line Chemotherapy

Download Full-text

Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy—the P-SELECT trial (WJOG10617G)—a randomised phase II trial by the West Japan Oncology Group

BMC Cancer ◽

10.1186/s12885-020-07047-1 ◽

2020 ◽

Vol 20 (1) ◽

Cited By ~ 1

Author(s):

Kenro Hirata ◽

Yasuo Hamamoto ◽

Masahiko Ando ◽

Chiyo K. Imamura ◽

Kenichi Yoshimura ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Peritoneal Dissemination ◽

Oncology Group ◽

First Line ◽

The West ◽

First Line Therapy ◽

Line Therapy ◽

Select Trial

Download Full-text

Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma

Investigational New Drugs ◽

10.1007/s10637-013-0054-5 ◽

2013 ◽

Vol 32 (1) ◽

pp. 188-194 ◽

Cited By ~ 6

Author(s):

Ajjai Alva ◽

Stephanie Daignault ◽

David C. Smith ◽

Maha Hussain

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Advanced Urothelial Carcinoma

Download Full-text

672 Randomised phase II trial (M77001) of trastuzumab (Herceptin®) plus docetaxel versus docetaxel alone, as first-line therapy in patients with HER2-positive metastitic breast cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90703-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S202 ◽

Cited By ~ 15

Author(s):

J.-M. Extra ◽

F. Cognetti ◽

S. Chan ◽

D. Maraninchi ◽

R. Snyder ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Her2 Positive ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer

Cancer Research and Treatment ◽

10.4143/crt.2005.37.6.332 ◽

2005 ◽

Vol 37 (6) ◽

pp. 332

Author(s):

Nam-Su Lee ◽

Hee-Sook Park ◽

Jong-Ho Won ◽

Dae-Sik Hong ◽

Su-Taek Uh ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Phase-II trial of taxotere (TXT) and Navelbine (N) as first-line therapy in patients (PTS) with advanced non-small cell lung cancer (ANSCLC)

Lung Cancer ◽

10.1016/s0169-5002(99)90743-2 ◽

1999 ◽

Vol 25 ◽

pp. S19-S20

Author(s):

M. O'Rourke ◽

D. Garfield ◽

P. Ellis

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.7-5-410 ◽

2002 ◽

Vol 7 (5) ◽

pp. 410-417 ◽

Cited By ~ 107

Author(s):

Mohammad Jahanzeb ◽

Joanne E. Mortimer ◽

Furhan Yunus ◽

David H. Irwin ◽

James Speyer ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2006.60.1.57 ◽

2006 ◽

Vol 60 (1) ◽

pp. 57 ◽

Cited By ~ 1

Author(s):

Hye Cheol Jeong ◽

Sang Yeub Lee ◽

Jung Ha Kim ◽

Eun Sil Ha ◽

Jin Yong Jung ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text